These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30010036)

  • 1. 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer.
    Zhang J; Han X; Gao C; Xing Y; Qi Z; Liu R; Wang Y; Zhang X; Yang YG; Li X; Sun B; Tian X
    Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):187-199. PubMed ID: 30010036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
    Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
    Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
    Song CX; Yin S; Ma L; Wheeler A; Chen Y; Zhang Y; Liu B; Xiong J; Zhang W; Hu J; Zhou Z; Dong B; Tian Z; Jeffrey SS; Chua MS; So S; Li W; Wei Y; Diao J; Xie D; Quake SR
    Cell Res; 2017 Oct; 27(10):1231-1242. PubMed ID: 28820176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.
    Mastoraki S; Balgkouranidou I; Tsaroucha E; Klinakis A; Georgoulias V; Lianidou E
    Mol Oncol; 2021 Sep; 15(9):2412-2422. PubMed ID: 33159839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer.
    Ezzeldin N; El-Lebedy D; Hassan M; Shalaby AO; Hussein SAM; Gharib AM; Hamdy G; Mohammed AM; Ramadan A; Sobeih ME
    J Egypt Natl Canc Inst; 2024 Jun; 36(1):21. PubMed ID: 38880832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer.
    Palmero R; Taus A; Viteri S; Majem M; Carcereny E; Garde-Noguera J; Felip E; Nadal E; Malfettone A; Sampayo M; Riva F; Nagy RJ; Lanman RB; Faull I; Dix D; Karachaliou N; Rosell R
    JCO Precis Oncol; 2021 Nov; 5():93-102. PubMed ID: 34994593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    West-Szymanski DC; Zhang Z; Cui XL; Kowitwanich K; Gao L; Deng Z; Dougherty U; Williams C; Merkle S; He C; Zhang W; Bissonnette M
    JCO Precis Oncol; 2024 Oct; 8():e2400277. PubMed ID: 39393034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer.
    Hu X; Luo K; Shi H; Yan X; Huang R; Zhao B; Zhang J; Xie D; Zhang W
    Clin Epigenetics; 2022 Jan; 14(1):15. PubMed ID: 35073982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of circulating tumor DNA methylation in non-small cell lung cancer].
    Yang Lan L; Chen Bojiang BJ; Li Lei L
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):967-970. PubMed ID: 30522195
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.
    Tong X; Chen W; Ye L; Xiong Y; Xu Y; Luo Y; Xia X; Xu Z; Lin Y; Zhu X; Wang N; Xue X; Zhang H; Guo G
    Lupus Sci Med; 2024 Oct; 11(2):. PubMed ID: 39366755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma.
    Chen B; Wang D; Xu Y; Guo Q; Pan J; Yu S; Fang Y; Xiao S; Ruan Y; Yang S; Lin M; Hong J; Zhan Z; Lin S
    Eur J Cancer; 2024 Oct; 210():114294. PubMed ID: 39213787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.
    Chen C; Huang X; Yin W; Peng M; Wu F; Wu X; Tang J; Chen M; Wang X; Hulbert A; Brock MV; Liu W; Herman JG; Yu F
    Clin Epigenetics; 2020 Mar; 12(1):39. PubMed ID: 32138766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Szpechcinski A; Rudzinski P; Kupis W; Langfort R; Orlowski T; Chorostowska-Wynimko J
    Cancer Lett; 2016 May; 374(2):202-7. PubMed ID: 26854716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.